Desai Antal Rohit 4

What Happened

• Antal Rohit Desai, a director of PROCEPT BioRobotics Corp (PRCT), received equity awards on June 9, 2026: 3,315 restricted stock units (RSUs) and a 5,853-share derivative award (stock option). Both grants were issued at $0.00 (no cash paid). Combined, the awards represent potential ownership of 9,168 common shares if all RSUs vest and options are exercised.

Key Details

• Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely).
• Awards: 3,315 RSUs (each RSU converts to one share upon vesting) and a 5,853-share stock option/derivative award; acquisition price listed as $0.00.
• Vesting: Both awards vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting following the grant date, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Transaction type code: A = Award/Grant. No sale or purchase reported.

Context

• These are grants (compensation), not open-market purchases or sales, so they reflect equity compensation rather than an immediate bullish or bearish trading signal.
• RSUs represent a contingent right to receive shares upon vesting; the derivative award is a stock option-type grant that vests on the same schedule. Nothing in the filing indicates immediate sale, tax-withholding, or a 10b5-1 plan.